Visit us at AACE2024 (Booth 212) and AAES (Booth 200)

Effective April 1, 2021, ThyGeNEXT® will be billed with Proprietary Laboratory Analysis (PLA) CPT code 0245U

Oncology (thyroid), mutation analysis of 10 genes and 37 RNA fusions and expression of 4 mRNA markers using next-generation sequencing, fine needle aspirate, report includes associated risk of malignancy expressed as a percentage.

Simple Ordering Process

Request complimentary ThyGeNEXT®/ThyraMIR®v2 Sample Collection Kits

Collect a specimen for testing when performing FNA

Added Convenience of Testing from Cytology Slides

Mail back the samples and requisition form

Interpace allows clients to use their own local cytopathology services. For those customers looking for an alternate option, Interpace offers comprehensive cytology services via our partner laboratories, including our national provider, Dianon (LabCorp).

Interpace Diagnostics Directory of Services


Interpace has arrangements with distributors in many countries to make our products available to local physicians and hospitals.


Requisition Forms


ThyGeNEXT + ThyraMIRv2 Test Process


FNA sample within provided collection buffer or PAP-stained smear, Diff-Quik®, Giemsa-stained, and ThinPrep® Slides

Sample Accessioned

Total Nucleic Acid Extraction

ThyGeNEXT testing with reflex to ThyraMIRv2 when needed

Result Report Sent to Client